WO2018070441A1 - Method for producing culture cell structure - Google Patents
Method for producing culture cell structure Download PDFInfo
- Publication number
- WO2018070441A1 WO2018070441A1 PCT/JP2017/036866 JP2017036866W WO2018070441A1 WO 2018070441 A1 WO2018070441 A1 WO 2018070441A1 JP 2017036866 W JP2017036866 W JP 2017036866W WO 2018070441 A1 WO2018070441 A1 WO 2018070441A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cell
- cell sheet
- sheet laminate
- fiber
- production method
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/60—Materials for use in artificial skin
Definitions
- the present invention relates to a method for producing a cultured cell structure.
- An object of the present invention is to provide a production method for efficiently obtaining a three-dimensional structure of cultured cells by culturing stacked cell sheets.
- a cell sheet laminate in which two or more cell sheets are laminated on a cell placement part surface of a substrate placed in a container containing a liquid medium; and on the cell placement part of the substrate
- the cell sheet laminate is cultured in a liquid medium, and the substrate has a recess on the back surface of the cell mounting portion, and the substrate has the cell mounting portion facing the recess.
- a method for producing a cultured cell structure comprising at least one fiber penetrating, and culturing the cell sheet laminate in a state in which the fiber extends in the lamination direction.
- the present invention it is possible to provide a production method for efficiently obtaining a three-dimensional structure of cultured cells by culturing stacked cell sheets.
- FIG. 1 It is a schematic sectional drawing which shows typically an example of the cultivation method of the cell sheet laminated body which concerns on this embodiment. It is a figure which shows the expression level of the cell proliferation marker in a cultured cell structure. It is a figure which shows the expression level of the cell respiration marker in a cultured cell structure. It is a figure which shows the expression level of the cell respiration marker in a cultured cell structure. It is a figure which shows an example of the image which immunostained the hypoxia marker in the cultured cell structure which concerns on Example 1. FIG. It is a figure which shows an example of the image which immunostained the hypoxia marker in the cultured cell structure which concerns on the comparative example 1. FIG.
- FIG. 1 It is a figure which shows an example of the image which immunostained the cell proliferation marker in the cultured cell structure which concerns on Example 1.
- FIG. It is a figure which shows an example of the image which immunostained the cell proliferation marker in the cultured cell structure which concerns on the comparative example 1.
- FIG. It is a figure which shows an example of the image which immunostained the cell respiration marker in the cultured cell structure which concerns on Example 1.
- FIG. It is a figure which shows an example of the image which immunostained the cell respiration marker in the cultured cell structure which concerns on the comparative example 1.
- FIG. It is a figure which shows the expression level of the cell respiration marker in the cultured cell structure in connection with the comparative example 2, Example 5, and Example 6.
- a cell sheet laminate in which two or more cell sheets are laminated is placed on the surface of a cell placement portion of a substrate placed in a container that contains a liquid medium. And culturing the cell sheet laminate on the cell placement part of the base material in a liquid medium, the base material has a recess on the back surface of the cell placement part, and the base material is The cell sheet laminate is cultivated with at least one fiber penetrating the cell placement portion toward the recess, and the fiber extends in the stacking direction.
- the cell sheet laminate By culturing the cell sheet laminate on a substrate placed in a liquid medium with fibers, the cell sheet laminate can be efficiently cultured, and a three-dimensional cultured cell comprising cultured cells A structure can be manufactured efficiently.
- a cell sheet laminate in which two or more cell sheets are laminated is placed on the surface of a cell placement portion of a substrate placed in a container that contains a liquid medium.
- the size, shape, and material of the container for storing the liquid medium are not particularly limited as long as the liquid medium and the substrate can be disposed.
- Examples of the container include a polystyrene petri dish having a diameter of 3.5 to 15 cm, a 6-well plate, and the like.
- the liquid medium is prepared using a medium selected according to the cell type constituting the cell sheet laminate to be cultured as a basal medium.
- a basal medium for example, IMDM medium, Medium 199 medium, Eagle's Minimum Essential Medium (EMEM) medium, ⁇ MEM medium, Dolbecco's modified Eagle's Medium (DMEM) medium, Ham's F16h medium, RP 's medium and mixed medium thereof can be mentioned.
- Serum may be contained in the liquid medium.
- the liquid medium may be, for example, albumin, transferrin, sodium selenite, ITS-X (Invitrogen) (containing insulin, transferrin, sodium selenite), Knockout Serum Replacement (KSR) (when ES cells are cultured).
- FBS serum replacement N2 supplement (Invitrogen), B27 supplement (Invitrogen), fatty acid, insulin, collagen precursor, trace element, 2-mercaptoethanol, 3'-thiolglycerol, etc. May be included.
- lipids lipids, essential amino acids, L-glutamine, Glutamax, non-essential amino acids, vitamins, growth factors, low molecular compounds, antibiotics, antioxidants, pyruvate, buffers, inorganic salts, etc.
- An additive may be included.
- the base material on which the cell sheet laminate is placed has at least a cell placement portion, and has a recess on the back surface of the cell placement portion.
- the shape of the cell placement portion include a rectangular shape, a polygonal shape such as a triangular shape, a substantially circular shape, and an elliptical shape. What is necessary is just to select the magnitude
- the size of the cell placement portion is 0.5 cm or more in diameter, and preferably 1 cm or more. Moreover, it is 10 cm or less, Preferably it is 5 cm or less.
- the thickness of the base material that is, the height in the direction perpendicular to the surface of the cell placement portion is appropriately selected according to the height of the container and the like, for example, 0.1 mm or more and 20 mm or less, preferably 1 mm or more and 15 mm or less. is there.
- the back surface of the cell placement portion of the base material may have a wall portion that forms a recess together with the back surface of the cell placement portion.
- the end portion of the wall portion opposite to the cell placement portion may be in contact with the bottom surface of the inner wall of the container or may be spaced apart. It is preferable that at least a part of the end portion of the wall portion of the base material is in contact with the bottom surface of the inner wall of the container.
- the size of the concave portion is, for example, 0.1 cm to 10 cm, and preferably 1 cm to 5 cm, as the height of the wall portion forming the concave portion.
- the wall thickness is, for example, 0.1 mm to 5 mm, preferably 1 mm to 2 mm.
- the base material examples include polystyrene (PS), polyethylene (PE), polyethylene terephthalate (PET), nylon, polytetrafluoroethylene (PTFE), ethylene-tetrafluoroethylene copolymer (ETFE), and tetrafluoroethylene- Examples thereof include hexafluoropropylene copolymer (FEP), tetrafluoroethylene-perfluoroalkyl vinyl ether copolymer (PFA), polydimethylsiloxane (PDMS), and the like.
- PS polystyrene
- PE polyethylene
- PET polyethylene terephthalate
- nylon nylon
- PTFE polytetrafluoroethylene
- ETFE ethylene-tetrafluoroethylene copolymer
- tetrafluoroethylene- Examples thereof include hexafluoropropylene copolymer (FEP), tetrafluoroethylene-perfluoroalkyl vinyl ether copolymer (PFA
- the cell placement part of the substrate has permeability to gas or liquid.
- the cell placement part is made of a material selected from a porous material, a material having a mesh structure, and a material having a swelling property with respect to a liquid (preferably water). Preferably it is formed.
- the permeability is, for example, 10 pmol/s/cm 2 or more with respect to air, 600pmol / s / cm 2 or more.
- the cell placement part has swelling property with respect to the liquid or has a communicating hole, particularly excellent liquid permeability can be expected.
- the base material is placed in the container, for example, in the container so that the surface of the cell placement portion and the bottom surface of the inner wall of the container are substantially parallel.
- the cell placement surface of the substrate is located in the liquid medium, and the distance from the bottom surface of the inner wall of the container to the surface of the liquid culture medium is from the bottom surface of the inner wall of the container to the surface of the cell placement portion of the substrate.
- the base material is arranged such that the distance ratio is, for example, 0.1 or more and 0.95 or less, preferably 0.5 or more and 0.95 or less.
- Cell sheet laminated body A cell sheet laminated body is mounted on the cell mounting part surface of a base material.
- a cell sheet laminate prepared in advance may be placed on the cell placement part surface, and the cell is placed on the cell placement part surface. You may mount by laminating
- the cell sheet laminate is produced by laminating the cell sheets on the carrier substrate, and the cell sheet laminate is placed on the cell placement portion surface together with the carrier substrate.
- the conveyance base material needs to be formed of at least a material having gas permeability, and more preferably formed of a material having gas permeability to a liquid in which the gas is dissolved.
- Specific examples of the substrate for conveyance include a porous film (hereinafter referred to as a VECELL film) constituting the bottom surface of VECELL Preset (trade name, manufactured by Bethel).
- the cell sheet laminate can be prepared by laminating two or more cell sheets.
- Examples of the method for laminating cell sheets include a method of laminating two or more cell sheets in a liquid medium and then removing the liquid medium.
- At least one inter-sheet fiber may be disposed between the cell sheets of the cell sheet laminate.
- the inter-sheet fibers are arranged such that the length direction thereof is parallel to the surface of the cell sheet.
- the at least one edge part of the fiber between sheets is located in the exterior of a cell sheet laminated body, ie, in a liquid culture medium.
- at least one end of the inter-sheet fibers may be outside the liquid medium.
- inter-sheet fibers are arranged between cell sheets, it is preferable to arrange one or more inter-sheet fibers per cell sheet, for example. Moreover, it can be 1 to 10 per 1 cm 2 of the cell sheet area.
- the number of cell sheets constituting the cell sheet laminate is, for example, 2 or more and 100 or less, and preferably 2 or more and 50 or less.
- the thickness in the stacking direction of the cell sheet laminate is, for example, 20 ⁇ m or more, preferably 500 ⁇ m or more, for example, 10 mm or less, preferably 8 mm or less.
- the area of the surface perpendicular to the stacking direction of the cell sheet laminate is, for example, 0.15 cm 2 or more, preferably 7 cm 2 or more, and 80 cm 2 or less, preferably 10 cm 2 or less.
- the cell sheet constituting the cell sheet laminate is a sheet-like cell aggregate composed of one layer formed by adhering a plurality of cells.
- the cells constituting the cell sheet are not particularly limited and can be appropriately selected depending on the purpose and the like.
- the cells constituting the cell sheet are mammalian cells including humans, and examples include somatic cells, precursor cells thereof, and mixed cells thereof.
- Specific cells include endothelial cells, mesenchymal stem cells, adipose-derived stem cells, cord blood-derived stem cells, dental pulp stem cells, cardiomyocytes, heart wall cells, hepatocytes, fibroblasts, osteoblasts, vascular endothelial cells, liver
- Examples include progenitor cells, mesenchymal cells, islet cells, chondrocytes, epithelial cells, and the like, and at least one cell selected from the group consisting of these is preferred.
- the cells constituting the cell sheet may be cells contained in a tissue isolated by an arbitrary method, or may be a cell line established from the tissue.
- cells derived from pluripotent stem cells by any method may be used.
- the guidance method used at this time can be a method well known to those skilled in the art, and is not particularly limited.
- the cell sheet can be produced by culturing desired cells in a sheet form in a culture device and taking out the cells in a sheet state.
- a method for taking out the cultured cells in a sheet state for example, after culturing the cells using a culture device coated with a temperature-responsive polymer to form a cell sheet, the cell sheet is removed from the culture device by changing the temperature.
- the method of peeling can be mentioned.
- the temperature-responsive polymer include (meth) acrylamide compounds, N- (or N, N-di) alkyl-substituted (meth) acrylamide derivatives (see, for example, JP 2010-255001 A), or vinyl ether derivative polymers. Can be mentioned.
- a culture device fixed with poly-N-isopropylacrylamide is exemplified.
- Such culture equipment can also be purchased from Cellseed as UpCell.
- a culture device coated with a temperature-responsive coating agent a culture device coated with methyl cellulose described in Chen CH, et al, Biomacromolecules. 7: 736-43, 2006, Takamoto Y, et al, A culture apparatus having a polyethylene terephthalate (PET) film coated with a block copolymer of 2-ethoxyethyl vinyl ether and 2-phenoxyethyl vinyl ether described in J. Biomater. Sci. Polymer Edn, 18: 1211-1222, 2007 Illustrated.
- PET polyethylene terephthalate
- the cell sheet laminate placed on the cell placement part of the substrate is cultured in a liquid medium.
- oxygen and the like are sufficiently supplied to the inside of the cell sheet laminate, and the cell culture is in good condition Done in Thereby, for example, cell adhesion and the like proceed between the cell sheets to form a cultured cell structure that can integrally exert a physiological function.
- the culture temperature is, for example, about 30 to 40 ° C, preferably about 37 ° C.
- the culture is performed, for example, in an atmosphere of CO 2 -containing air, and the CO 2 concentration is, for example, 2 to 5%.
- the culture time is, for example, 1 day to 10 days.
- Culturing may be performed in a state where air is retained in the recess of the substrate.
- the cell placement part of the base material is permeable to gas
- the bottom surface of the cell sheet laminate is also adhered and cultured in the culture solution.
- the effect that it becomes possible to culture in a state close to the gas-liquid interface is obtained.
- At least a part of the air held in the recess may be exchanged between the start of culture and the end of culture.
- the exchange amount can be appropriately selected according to the purpose or the like.
- a method for exchanging air held in the recess for example, a method of supplying / recovering air through a hollow gas exchange member having one opening in the recess can be cited.
- the air supplied to the recess may be released into the liquid medium from the cell mounting portion having gas permeability, and at least a part of the air may be recovered from the recess via the air exchange member.
- the air retained in the recess may contain a component that gives a stimulus to the cultured cells.
- components that stimulate cultured cells include nitric oxide, nitrogen, carbon monoxide, carbon dioxide, hydrogen hydrogen sulfide, oxygen, and the like.
- the concentration can be appropriately selected according to the nature, purpose, and the like of the component.
- Culturing may be performed in a state where the liquid medium is held in the recess of the base material.
- the liquid medium held in the recess may be the same as or different from the liquid medium stored in the container.
- the cell placement part of the base material is permeable to liquid, by culturing while holding the liquid medium in the recess, the cell sheet laminate can also be cultured from the bottom of the cell sheet while adhering culture in the liquid medium. The effect that the supply of nutrients and oxygen through a liquid medium becomes possible is obtained.
- At least a part of the liquid medium held in the recess may be exchanged between the start of culture and the end of culture. When exchanging the liquid culture medium held in the recess, the exchange amount can be appropriately selected according to the purpose or the like.
- a method of exchanging the liquid medium held in the recess for example, a method of supplying and recovering the liquid medium via a hollow liquid exchange member having one opening in the recess, or via a porous liquid exchange member And a method of exchanging the liquid medium.
- the liquid medium supplied to the recess through the hollow liquid exchange member may be discharged into the liquid medium from the cell mounting portion having liquid permeability, and at least a part of the liquid medium from the recess through the liquid exchange member. It may be recovered.
- a porous liquid exchange member is used, the liquid medium may be exchanged by diffusion.
- the liquid medium held in the recess may contain a component that stimulates the cultured cells.
- components that stimulate cultured cells include growth factors such as VEGF (Vascular endothelial growth factor) and bFGF (basic fibroblast growth factor), nitrogen monoxide, nitrogen, carbon monoxide, carbon dioxide, hydrogen, hydrogen sulfide, Examples thereof include oxygen.
- VEGF Vascular endothelial growth factor
- bFGF basic fibroblast growth factor
- nitrogen monoxide nitrogen, carbon monoxide, carbon dioxide
- hydrogen hydrogen sulfide
- oxygen oxygen
- the base material on which the cell sheet laminate is placed includes at least one fiber (filament) having one end penetrating into the cell placement portion and extending in the stacking direction of the cell sheet laminate.
- the fiber penetrates the cell placement portion toward the recess provided on the back surface of the cell placement portion.
- the fiber extended in the lamination direction of a cell sheet laminated body may be in contact with the cell sheet laminated body, and may penetrate the cell sheet laminated body. It is preferable that at least one of the fibers penetrates the cell sheet laminate. In particular, it is preferable that a plurality of fibers are arranged and most of the number of the fibers penetrates the cell sheet laminate.
- the number of non-penetrating fibers may be larger than the number of fibers that penetrate, and it consists only of fibers that do not penetrate the cell sheet laminate. May be.
- the fiber material examples include ethylene-tetrafluoroethylene copolymer (ETFE), tetrafluoroethylene-perfluoroalkyl vinyl ether copolymer (FEP), CYTOP (trade name, manufactured by Asahi Glass Co., Ltd.), and Flemion (trade name, Asahi Glass).
- Teflon AF1600 trade name, manufactured by Mitsui DuPont Fluorochemical Co., Ltd.
- Teflon AF2400 trade name, manufactured by Mitsui DuPont Fluorochemical Co., Ltd.
- PDMS polydimethylsiloxane
- the material is capable of supplying a medium.
- a fiber swells with a culture medium. When it swells, the supply of oxygen is improved along with the medium.
- the fiber structure may be any of a porous body, a hollow body, a solid body, and the like. From the viewpoint of exchanging liquid or gas with the concave portion, a porous body or a hollow body is preferable.
- the fiber is a porous body or a hollow body, the liquid or gas can be easily exchanged. That is, the fiber provided in the base material may serve as the gas exchange member or the liquid exchange member.
- the thickness of the fiber is, for example, 0.1 ⁇ m or more and 5000 ⁇ m or less as a diameter, preferably 1 ⁇ m or more and 1000 ⁇ m or less, and more preferably 10 ⁇ m or more and 500 ⁇ m or less.
- the diameter of the hollow portion is, for example, not less than 0.1 ⁇ m and not more than 5000 ⁇ m, preferably not less than 10 ⁇ m and not more than 500 ⁇ m.
- the length of a fiber will not be specifically limited if it is longer than the thickness of a cell sheet laminated body, For example, they are 2 mm or more and 50 mm or less, Preferably they are 5 mm or more and 30 mm or less.
- the number of fibers is, for example, from 0.01 to 1000, preferably from 0.1 to 100, and more preferably from 0.1 to 50, per 1 cm 2 of the cell sheet area.
- the ratio of the number of fibers penetrating the cell sheet laminate to the total number of fibers provided in the substrate is preferably 50% to 100%, more preferably 80% to 100%.
- FIG. 1 is a schematic cross-sectional view schematically showing an example of a method for culturing a cell sheet laminate according to the present embodiment.
- the liquid medium 16 is accommodated in the container 2, and the base material 4 is disposed inside the container 2.
- a cell sheet laminate 14 is placed on the surface of the cell placement portion 6 of the base 4 via a transport base 12.
- the cell sheet laminated body 14 may be directly mounted on the surface of the cell mounting part 6 without using the conveyance base material 12.
- a recess 8 is formed on the back surface of the cell placement unit 6, and a liquid medium 16 is held in the recess 8. Air may be held in the recess 8 instead of the liquid medium 16.
- the cell sheet laminate placed on the surface of the cell placement unit 6 is cultured at a position closer to the surface of the liquid medium than placed on the bottom surface 18 of the inner wall of the container.
- the base material 4 is provided with the fiber 10 which penetrates the cell mounting part 6 toward the recessed part 8, and the fiber 10 penetrates the cell sheet laminated body 14, and is extended in the lamination direction of the cell sheet laminated body 14. Yes.
- the fiber 10 penetrates the cell sheet laminate 14 in the lamination direction, but may contact the side surface of the cell sheet laminate 14 without penetrating the cell sheet laminate 14.
- one end of the fiber 10 is located in the recess 8 and the other end is located in the liquid medium, but the other end may be located outside the liquid medium 16. .
- the cultured cell structure produced by the production method of the present embodiment has a feature of maintaining high cell activity while having a thickness that causes necrosis inside the conventional culture method, such as drug discovery research and regenerative medicine. It can be applied to any use.
- the cultured cell structure was evaluated by immunostaining and Western blot analysis as described below.
- Immunostaining The obtained cultured cell structure was washed twice with phosphate buffered saline (PBS), fixed with 4% paraformaldehyde, solidified with OCT compound, sliced into 10 ⁇ m thickness with a cryostat, and frozen section. Was made. The frozen section was prepared so that a cross section parallel to the stacking direction could be observed. Immunostaining includes hypoxia probe (Hypoxyprobe), a hypoxia marker, pyruvate dehydrogenase (PDH) antibody (SANTA CRUZ BIOTECHNOLOGY), a cell respiration marker, Ki-67 antibody (Santa TA), a cell proliferation marker. BIOTECHNOLOGY). Images of immunostained cultured cell structures are shown in FIGS.
- PBS phosphate buffered saline
- the PVdF membrane was washed with TBST (Tris Buffered Saline with Tween 20), and then treated with an HRP (horseradish peroxidase) -conjugated secondary antibody. After the treatment for a predetermined time, it was washed again with TBST, treated with SuperSignal Chemiluminescent Substrate (Thermo scientific), and visualized using LAS4000 (trade name, manufactured by Fuji Film). The obtained image was subjected to relative quantification using image analysis software Image J. The evaluation results are shown in FIGS.
- a cell culture polystyrene 6-well plate is seeded with 2 mL of a medium in a human mesenchymal stem cell line (hMSC) to 200,000 cells / well, and cultured for 8 to 10 days while changing the medium every 3 days. A cell sheet was formed on the plate.
- hMSC human mesenchymal stem cell line
- Preparation of cell sheet laminate A 10 cm cell culture PS petri dish was treated with a 0.1% gelatin aqueous solution at room temperature for 10 minutes.
- the cell sheet formed as described above was peeled off by pipetting, and the peeled cell sheet was sucked with a decantation or pipette tip having a large diameter and transferred to a gelatin-coated PS petri dish.
- the medium was dripped with a pipette to stretch the cell sheet wrinkles.
- the dropped medium was sucked off and allowed to stand in an incubator at 37 ° C. and 5% CO 2 for 30 minutes to adhere the cell sheet to the petri dish.
- the next cell sheet is transferred to a petri dish together with the culture medium, stacked on the adhered cell sheet, and after dropping the culture medium with a pipette to stretch the cell sheet wrinkles, the culture medium is sucked off, and the medium is sucked at 37 ° C, 5% CO 2. In the incubator for 30 minutes to laminate the cell sheets.
- the cell sheet lamination operation was repeated a predetermined number of times to obtain a cell sheet laminate in which a predetermined number of cell sheets were laminated.
- a VECELL film was used as a transport substrate, and the laminate peeled off from the PS petri dish with a spatula or the like was adsorbed to the VECELL film and transferred to the placement section.
- the medium was poured directly into the laminate and cultured.
- the stacked body in which 3 to 10 sheets are stacked is transported onto another stacked body using a VECELL film, and the stacked body is peeled off. It can also be produced by sequentially laminating each other.
- Example 1 A cell sheet laminate comprising 5 cell sheets was placed on the bottom of the inner wall of a 10 cm cell culture PS petri dish, and 10 mL of MEM- ⁇ medium (10% fetal bovine serum, 1% penicillin / streptomycin) was added. Culturing was performed for a predetermined period in an incubator at 37 ° C. and 5% CO 2 . The cultured cell structure obtained after the culture was evaluated by immunostaining by the frozen section method and Western blot analysis. Images obtained by immunostaining the hypoxia marker, cell proliferation marker and cell respiration marker are shown in FIGS. 6, 8 and 10, respectively. The results of Western blot analysis are shown in FIGS.
- Example 1 CYTOP CTL-109S (trade name, manufactured by Asahi Glass Co., Ltd.) was coated on the outer surface of a syringe needle having an inner diameter of 400 ⁇ m to produce a hollow filament having a wall thickness of about 30 ⁇ m.
- the SEM image of the produced hollow filament is shown in FIG.
- the left figure of FIG. 12 is an image with a magnification of 100 times, and the right figure is an image with a magnification of 1000 times.
- the hollow filament is penetrated through the cell sheet laminate, the VECELL membrane and the dish bottom together with the syringe needle, and the filament
- the syringe needle was pulled out while pressing with tweezers.
- the remaining filament was in a state where one end was in the dish and the other end was exposed to the air from the medium surface.
- the cell sheet was the same as Comparative Example 2 except that the filaments were arranged in a state of penetrating the cell sheet laminate at a rate of 2 per 0.8 cm 2 and that the number of laminated cell sheets was 5.
- Laminates were cultured and evaluated by immunostaining by Western section and Western blot analysis. The evaluation results are shown in FIGS. Moreover, the image which immunostained the hypoxia marker, the cell proliferation marker, and the cell respiration marker is shown in FIG.5, FIG.7 and FIG.9, respectively.
- Example 2 The cell sheet laminate was cultured and evaluated in the same manner as in Example 1 except that Teflon AF1600 (trade name, manufactured by Mitsui DuPont Fluorochemical Co., Ltd.) was used instead of CYTOP CTL-109S. Results similar to 1 were obtained.
- Teflon AF1600 trade name, manufactured by Mitsui DuPont Fluorochemical Co., Ltd.
- CYTOP CTL-109S was coated on the outer surface of a syringe needle having an inner diameter of 400 ⁇ m to produce a hollow filament. After placing the cell sheet laminate formed on the VECELL membrane on the bottom of the dish, the hollow filament is passed through the cell sheet laminate, the VECELL membrane and the bottom of the dish together with the syringe needle, and the syringe needle while pressing the filament with tweezers Pulled out. The remaining filament was in a state where one end was in the dish and the other end was exposed to the air from the medium surface.
- the cell sheet laminate was cultured in the same manner as in Example 1 except that only one filament was disposed so as to penetrate the center of the cell sheet laminate.
- the cell sheet laminate was punched out to 5 mm ⁇ centering on the position where the fiber penetrated, and the expression level of PDH as a cell respiration marker was evaluated in the same manner as in Example 1.
- the evaluation results are shown in FIG.
- the vertical axis in FIG. 4 is the PDH expression level corrected with the actin expression level.
- Example 3 The cell sheet laminate was cultured and evaluated in the same manner as in Example 3 except that only one 400 ⁇ m diameter syringe needle was used instead of the filament so as to penetrate the center of the cell sheet laminate. The evaluation results are shown in FIG.
- FIG. 4 shows that the amount of PDH expressed was higher in Example 3 using fibers than in Comparative Example 3 using syringe needles. In the one-sided test, a significant difference was recognized at a significance level of 5%.
- Example 4 When the cell sheet laminate was cultured and evaluated in the same manner as in Example 3 except that Teflon AF1600 was used instead of CYTOP CTL-109S, the same results as in Example 3 were obtained.
- FIG. 13 shows an SEM image of the produced hollow filament.
- the left figure of FIG. 13 is an image with a magnification of 100 times, and the right figure is an image with a magnification of 1000 times. The evaluation results are shown in FIG.
- Example 6 Flemion EW909 was used in place of CYTOP CTL-109S, a gelatin film was precoated as a sacrificial layer on the outer surface of the syringe needle, and Flemion was annealed in an oven at 120 ° C. for 10 minutes at a rate of 3 per 1.76 cm 2.
- the cell sheet laminate was cultured and evaluated by Western blot analysis in the same manner as in Comparative Example 2 except that the filament was disposed in a state of penetrating the cell sheet laminate. The evaluation results are shown in FIG. It can be seen from FIG. 11 that Comparative Example 2 using no fiber showed significantly higher PDH expression in Examples 5 and 6 using fiber. Moreover, the tendency for the PDH expression level to become higher is seen when the number of fibers is three than one.
- Example 7 A hollow filament was prepared by coating gelatin hydrogel on the outer surface of a syringe needle having an inner diameter of 400 ⁇ m and thermally crosslinking in a vacuum oven at 140 ° C. for 72 hours.
- the cell sheet laminate was cultured and evaluated in the same manner as in Example 3 except that a crosslinked gelatin hydrogel was used instead of CYTOP CTL-109S, and the same results as in Example 3 were obtained. .
- Example 8 Flemion EW909 was used instead of CYTOP CTL-109S, a gelatin film was precoated as a sacrificial layer on the outer surface of the syringe needle, Flemion EW909 was annealed in an oven at 120 ° C. for 10 minutes, and between the cell sheets.
- a cell sheet laminate was cultured in the same manner as in Example 3 except that 45 sheets were laminated by sandwiching gelatin hydrogel particles having a particle diameter of 20 ⁇ m to 32 ⁇ m by the method described in 1. After culturing for a predetermined period and examining whether the cell sheet laminate was stably held on the substrate, the laminate was stably held on the substrate even after culturing for 2 days or more.
- Example 4 A cell sheet laminate in which gelatin hydrogel particles having a particle diameter of 20 ⁇ m to 32 ⁇ m were sandwiched between the cell sheets by the method described in Patent Document 2 and 45 cell sheets were stacked was not disposed in the dish.
- the cell sheet laminate was cultured in the same manner as in Example 1 except that it was placed on the bottom of the inner wall, and it was examined whether the cell sheet laminate was stably cultured on a petri dish. As a result, on the second day of culture, the cell sheet laminate peeled from the petri dish and contracted, or peeled between the sheets and fell apart. It should be noted that the entire content of the specification, claims, drawings and abstract of Japanese Patent Application No. 2016-200864 filed on October 12, 2016 is cited herein as the disclosure of the specification of the present invention. Incorporated.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Botany (AREA)
- Cell Biology (AREA)
- Zoology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
本発明は、培養細胞構造体の製造方法に関する。 The present invention relates to a method for producing a cultured cell structure.
近年、疾患、損傷等により細胞を欠損した組織へ細胞を補充する医療として、細胞シートを用いる細胞移植治療が検討されている。例えば複数の細胞シートを用いて腎臓や肝臓などの組織の作製が検討されている。これらの組織は、複雑な3次元構造を有し、多種の細胞が組織化されているため、細胞を培養するだけで組織化することは困難である。そのため、細胞外マトリクスの形成とその上で細胞を培養することを繰り返す三次元組織の製造方法が提案されている(例えば、特許文献1参照)。また細胞を2次元的に増殖させて得られた細胞シートを重ね合わせて、積層化細胞シートを製造する方法が提案されている(例えば、特許文献2参照)。 In recent years, cell transplantation treatment using a cell sheet has been studied as a medical treatment for replenishing cells to a tissue deficient due to disease, damage or the like. For example, production of tissues such as kidneys and livers using a plurality of cell sheets has been studied. Since these tissues have a complicated three-dimensional structure and various types of cells are organized, it is difficult to organize them only by culturing the cells. Therefore, a method for producing a three-dimensional tissue in which formation of an extracellular matrix and culturing of cells thereon are repeated has been proposed (see, for example, Patent Document 1). In addition, a method for producing a laminated cell sheet by superposing cell sheets obtained by two-dimensionally growing cells has been proposed (see, for example, Patent Document 2).
本発明は、積層化された細胞シートを培養することで、培養細胞の三次元的な構造体を効率よく得るための製造方法を提供することを課題とする。 An object of the present invention is to provide a production method for efficiently obtaining a three-dimensional structure of cultured cells by culturing stacked cell sheets.
上記課題を解決するための具体的手段は以下の通りである。
液体培地を収容する容器内に配置される基材の細胞載置部表面上に、2以上の細胞シートが積層された細胞シート積層体を載置することと、基材の細胞載置部上の細胞シート積層体を、液体培地中で培養することと、を含み、上記基材は細胞載置部裏面に凹部を有し、上記基材は、上記凹部に向けて上記細胞載置部を貫通する少なくとも1本の繊維を備え、細胞シート積層体を、当該繊維が積層方向に延在する状態で培養する、培養細胞構造体の製造方法である。
Specific means for solving the above problems are as follows.
Placing a cell sheet laminate in which two or more cell sheets are laminated on a cell placement part surface of a substrate placed in a container containing a liquid medium; and on the cell placement part of the substrate The cell sheet laminate is cultured in a liquid medium, and the substrate has a recess on the back surface of the cell mounting portion, and the substrate has the cell mounting portion facing the recess. A method for producing a cultured cell structure, comprising at least one fiber penetrating, and culturing the cell sheet laminate in a state in which the fiber extends in the lamination direction.
本発明によれば、積層化された細胞シートを培養することで、培養細胞の三次元的な構造体を効率よく得るための製造方法を提供することができる。 According to the present invention, it is possible to provide a production method for efficiently obtaining a three-dimensional structure of cultured cells by culturing stacked cell sheets.
本発明の培養細胞構造体の製造方法は、液体培地を収容する容器内に配置される基材の細胞載置部表面上に、2以上の細胞シートが積層された細胞シート積層体を載置することと、基材の細胞載置部上の細胞シート積層体を、液体培地中で培養することと、を含み、上記基材は細胞載置部裏面に凹部を有し、上記基材は、上記凹部に向けて上記細胞載置部を貫通する少なくとも1本の繊維を備え、細胞シート積層体を、当該繊維が積層方向に延在する状態で培養する。細胞シート積層体を液体培地中に配置される基材上で繊維を備えた状態で培養することで、細胞シート積層体の培養が効率的に行われ、培養細胞からなる三次元的な培養細胞構造体を効率的に製造することができる。特に、上記繊維の少なくとも1本は前記細胞シート積層体を貫通していることが好ましい。これは例えば、繊維を介して細胞シート積層体内部へ効率的に酸素や栄養が供給されるためだと考えることができる。 In the method for producing a cultured cell structure according to the present invention, a cell sheet laminate in which two or more cell sheets are laminated is placed on the surface of a cell placement portion of a substrate placed in a container that contains a liquid medium. And culturing the cell sheet laminate on the cell placement part of the base material in a liquid medium, the base material has a recess on the back surface of the cell placement part, and the base material is The cell sheet laminate is cultivated with at least one fiber penetrating the cell placement portion toward the recess, and the fiber extends in the stacking direction. By culturing the cell sheet laminate on a substrate placed in a liquid medium with fibers, the cell sheet laminate can be efficiently cultured, and a three-dimensional cultured cell comprising cultured cells A structure can be manufactured efficiently. In particular, it is preferable that at least one of the fibers penetrates the cell sheet laminate. This can be considered to be because, for example, oxygen and nutrients are efficiently supplied into the cell sheet laminate through fibers.
培養細胞構造体の製造方法では、液体培地を収容する容器内に配置される基材の細胞載置部表面上に、2以上の細胞シートが積層された細胞シート積層体が載置される。液体培地を収容する容器の大きさ、形状及び材質は、液体培地及び基材を配置可能であれば特に制限されない。容器としては、例えば直径が3.5~15cmのポリスチレン製シャーレ、6wellプレート等を挙げることができる。 In the method for producing a cultured cell structure, a cell sheet laminate in which two or more cell sheets are laminated is placed on the surface of a cell placement portion of a substrate placed in a container that contains a liquid medium. The size, shape, and material of the container for storing the liquid medium are not particularly limited as long as the liquid medium and the substrate can be disposed. Examples of the container include a polystyrene petri dish having a diameter of 3.5 to 15 cm, a 6-well plate, and the like.
液体培地
液体培地は培養する細胞シート積層体を構成する細胞種等に応じて選択される培地を基礎培地として調製される。基礎培地としては、例えばIMDM培地、Medium199培地、Eagle’s Minimum Essential Medium(EMEM)培地、αMEM培地、Doulbecco’s modified Eagle’s Medium(DMEM)培地、Ham’s F12培地、RPMI 1640培地、Fisher’s培地、及びこれらの混合培地を挙げることができる。
Liquid Medium The liquid medium is prepared using a medium selected according to the cell type constituting the cell sheet laminate to be cultured as a basal medium. As the basal medium, for example, IMDM medium, Medium 199 medium, Eagle's Minimum Essential Medium (EMEM) medium, αMEM medium, Dolbecco's modified Eagle's Medium (DMEM) medium, Ham's F16h medium, RP 's medium and mixed medium thereof can be mentioned.
液体培地には、血清が含まれていてもよい。また液体培地は、必要に応じて例えば、アルブミン、トランスフェリン、亜セレン酸ナトリウム、ITS-X(Invitrogen)(インスリン、トランスフェリン、亜セレン酸ナトリウム含有)、Knockout Serum Replacement(KSR)(ES細胞培養時のFBSの血清代替物)、N2サプリメント(Invitrogen)、B27サプリメント(Invitrogen)、脂肪酸、インスリン、コラーゲン前駆体、微量元素、2-メルカプトエタノール、3’-チオールグリセロールなどの1つ以上の血清代替物を含んでもよい。さらに、脂質、必須アミノ酸、L-グルタミン、Glutamax、非必須アミノ酸、ビタミン、増殖因子、低分子化合物、抗生物質、抗酸化剤、ピルビン酸、緩衝剤、無機塩類などから選択される1種以上の添加剤を含んでいてもよい。 Serum may be contained in the liquid medium. The liquid medium may be, for example, albumin, transferrin, sodium selenite, ITS-X (Invitrogen) (containing insulin, transferrin, sodium selenite), Knockout Serum Replacement (KSR) (when ES cells are cultured). FBS serum replacement), N2 supplement (Invitrogen), B27 supplement (Invitrogen), fatty acid, insulin, collagen precursor, trace element, 2-mercaptoethanol, 3'-thiolglycerol, etc. May be included. Furthermore, one or more selected from lipids, essential amino acids, L-glutamine, Glutamax, non-essential amino acids, vitamins, growth factors, low molecular compounds, antibiotics, antioxidants, pyruvate, buffers, inorganic salts, etc. An additive may be included.
基材
細胞シート積層体が載置される基材は、少なくとも細胞載置部を有し、該細胞載置部の裏面に凹部を有する。細胞載置部の形状としては、矩形状、三角形状等の多角形状、略円形状、楕円形状等を挙げることができる。細胞載置部の大きさは培養する細胞シート積層体の大きさ、容器の大きさ等に応じて適宜選択すればよい。細胞載置部の大きさは、例えば、略円形の場合には直径として0.5cm以上であり、好ましくは1cm以上である。また10cm以下であり、好ましくは5cm以下である。
The base material on which the cell sheet laminate is placed has at least a cell placement portion, and has a recess on the back surface of the cell placement portion. Examples of the shape of the cell placement portion include a rectangular shape, a polygonal shape such as a triangular shape, a substantially circular shape, and an elliptical shape. What is necessary is just to select the magnitude | size of a cell mounting part suitably according to the magnitude | size of the cell sheet laminated body to culture | cultivate, the magnitude | size of a container, etc. FIG. For example, in the case of a substantially circular shape, the size of the cell placement portion is 0.5 cm or more in diameter, and preferably 1 cm or more. Moreover, it is 10 cm or less, Preferably it is 5 cm or less.
基材の厚み、すなわち、細胞載置部の表面に直交する方向の高さは容器の高さ等に応じて適宜選択され、例えば0.1mm以上20mm以下であり、好ましくは1mm以上15mm以下である。 The thickness of the base material, that is, the height in the direction perpendicular to the surface of the cell placement portion is appropriately selected according to the height of the container and the like, for example, 0.1 mm or more and 20 mm or less, preferably 1 mm or more and 15 mm or less. is there.
基材の細胞載置部の裏面には、細胞載置部の裏面と共に凹部を形成する壁部を有していてもよい。細胞載置部とは反対側の壁部の端部は、容器の内壁の底面に接していてもよいし、離隔されていてもよい。基材の壁部の端部は、少なくとも一部が容器内壁の底面に接していることが好ましい。 The back surface of the cell placement portion of the base material may have a wall portion that forms a recess together with the back surface of the cell placement portion. The end portion of the wall portion opposite to the cell placement portion may be in contact with the bottom surface of the inner wall of the container or may be spaced apart. It is preferable that at least a part of the end portion of the wall portion of the base material is in contact with the bottom surface of the inner wall of the container.
凹部の大きさは、凹部を形成する壁部の高さとして、例えば0.1cmから10cmであり、1cmから5cmが好ましい。また壁部の厚みは、例えば0.1mmから5mmであり、1mmから2mmが好ましい。 The size of the concave portion is, for example, 0.1 cm to 10 cm, and preferably 1 cm to 5 cm, as the height of the wall portion forming the concave portion. The wall thickness is, for example, 0.1 mm to 5 mm, preferably 1 mm to 2 mm.
基材の材質としては例えば、ポリスチレン(PS)、ポリエチレン(PE)、ポリエチレンテレフタレート(PET)、ナイロン、ポリテトラフルオロエチレン(PTFE)、エチレン-テトラフルオロエチレン共重合体(ETFE)、テトラフルオロエチレン-ヘキサフルオロプロピレン共重合体(FEP)、テトラフルオロエチレン-パーフルオロアルキルビニルエーテル共重合体(PFA)、ポリジメチルシロキサン(PDMS)等を挙げることができる。基材は単一の材料から形成されていてもよく、細胞載置部とその他の部分(例えば壁部)とがそれぞれ異なる材料で形成されていてもよい。 Examples of the base material include polystyrene (PS), polyethylene (PE), polyethylene terephthalate (PET), nylon, polytetrafluoroethylene (PTFE), ethylene-tetrafluoroethylene copolymer (ETFE), and tetrafluoroethylene- Examples thereof include hexafluoropropylene copolymer (FEP), tetrafluoroethylene-perfluoroalkyl vinyl ether copolymer (PFA), polydimethylsiloxane (PDMS), and the like. The base material may be formed of a single material, and the cell placement portion and other portions (for example, wall portions) may be formed of different materials.
基材の細胞載置部は、気体又は液体に対する透過性を有することが好ましい。細胞載置部が気体又は液体に対する透過性を有する場合、細胞載置部は、多孔質材料、メッシュ構造を有する材料、液体(好ましくは水)に対して膨潤性を有する材料から選ばれる材料から形成されることが好ましい。
基材の細胞載置部が気体に対する透過性を有する場合、その透過性は、例えば空気に対して10pmol/s/cm2以上であり、600pmol/s/cm2以上が好ましい。また細胞載置部が、液体に対して膨潤性を有する場合、もしくは連通孔を有する場合には、特に優れた液透過性が期待できる。
It is preferable that the cell placement part of the substrate has permeability to gas or liquid. When the cell placement part is permeable to gas or liquid, the cell placement part is made of a material selected from a porous material, a material having a mesh structure, and a material having a swelling property with respect to a liquid (preferably water). Preferably it is formed.
When cells mounting portion of the substrate has a permeability to gas, the permeability is, for example, 10 pmol/s/cm 2 or more with respect to air, 600pmol / s / cm 2 or more. In addition, when the cell placement part has swelling property with respect to the liquid or has a communicating hole, particularly excellent liquid permeability can be expected.
基材は、容器内に配置され、例えば、細胞載置部表面と容器の内壁の底面とが略平行になるように容器内に配置される。また、基材の細胞載置部表面は、液体培地内に位置し、容器の内壁の底面から液体培地の表面までの距離に対する、容器の内壁の底面から基材の細胞載置部表面までの距離の比が、例えば0.1以上0.95以下、好ましくは0.5以上0.95以下となるように基材が配置されることがより好ましい。 The base material is placed in the container, for example, in the container so that the surface of the cell placement portion and the bottom surface of the inner wall of the container are substantially parallel. In addition, the cell placement surface of the substrate is located in the liquid medium, and the distance from the bottom surface of the inner wall of the container to the surface of the liquid culture medium is from the bottom surface of the inner wall of the container to the surface of the cell placement portion of the substrate. More preferably, the base material is arranged such that the distance ratio is, for example, 0.1 or more and 0.95 or less, preferably 0.5 or more and 0.95 or less.
細胞シート積層体
基材の細胞載置部表面上には細胞シート積層体が載置される。細胞シート積層体を基材の細胞載置部表面に載置する方法としては、予め作製した細胞シート積層体を細胞載置部表面に載置してもよく、細胞載置部表面上で細胞シートを積層して細胞シート積層体を作製することで載置してもよい。
Cell sheet laminated body A cell sheet laminated body is mounted on the cell mounting part surface of a base material. As a method of placing the cell sheet laminate on the cell placement part surface of the base material, a cell sheet laminate prepared in advance may be placed on the cell placement part surface, and the cell is placed on the cell placement part surface. You may mount by laminating | stacking a sheet | seat and producing a cell sheet laminated body.
細胞シート積層体を予め作製する場合、搬送用基材上で細胞シートを積層することで細胞シート積層体を作製し、搬送用基材と共に細胞載置部表面上に細胞シート積層体を載置してもよい。搬送用基材は、少なくとも気体に対する透過性を有する材料で形成されていることが必要があり、気体が溶存した液体に対する気体透過性を有する材料で形成されていることがより好ましい。搬送用基材として具体的には例えば、VECELL Preset(商品名、ベセル社製)の底面を構成する多孔質膜(本明細書において、以下、VECELL膜という)等を挙げることができる。 When the cell sheet laminate is prepared in advance, the cell sheet laminate is produced by laminating the cell sheets on the carrier substrate, and the cell sheet laminate is placed on the cell placement portion surface together with the carrier substrate. May be. The conveyance base material needs to be formed of at least a material having gas permeability, and more preferably formed of a material having gas permeability to a liquid in which the gas is dissolved. Specific examples of the substrate for conveyance include a porous film (hereinafter referred to as a VECELL film) constituting the bottom surface of VECELL Preset (trade name, manufactured by Bethel).
細胞シート積層体は、2以上の細胞シートを積層することで調製することができる。細胞シートの積層方法としては、2以上の細胞シートを液体培地中で積層した後、液体培地を除去する方法を挙げることができる。また細胞シートの代わりに細胞シート積層体を積層することで細胞シート積層体を得てもよい。 The cell sheet laminate can be prepared by laminating two or more cell sheets. Examples of the method for laminating cell sheets include a method of laminating two or more cell sheets in a liquid medium and then removing the liquid medium. Moreover, you may obtain a cell sheet laminated body by laminating | stacking a cell sheet laminated body instead of a cell sheet.
細胞シート積層体の細胞シート間には、少なくとも1本のシート間繊維(フィラメント)が配置されていてもよい。シート間繊維は例えば、その長さ方向が細胞シートの面と平行に配置される。またシート間繊維の少なくとも一方の端部は、細胞シート積層体の外部、すなわち液体培地中に位置することが好ましい。また、別の形態ではシート間繊維の少なくとも一方の端部が液体培地の外に出ていてもよい。細胞シート間にシート間繊維が配置されることで、培養細胞構造体の形成がより効率的に進行する。シート間繊維の詳細については後述する基材が備える繊維と同様である。
細胞シート間にシート間繊維を配置する方法としては、細胞シートを積層する際に下層となる細胞シート上にシート間繊維を載置し、その上に上層となる細胞シートを積層することで、細胞シート間に配置することができる。
At least one inter-sheet fiber (filament) may be disposed between the cell sheets of the cell sheet laminate. For example, the inter-sheet fibers are arranged such that the length direction thereof is parallel to the surface of the cell sheet. Moreover, it is preferable that the at least one edge part of the fiber between sheets is located in the exterior of a cell sheet laminated body, ie, in a liquid culture medium. In another embodiment, at least one end of the inter-sheet fibers may be outside the liquid medium. By arranging the inter-sheet fibers between the cell sheets, the formation of the cultured cell structure proceeds more efficiently. About the detail of the fiber between sheets, it is the same as that of the fiber with which the base material mentioned later is provided.
As a method of arranging the inter-sheet fibers between the cell sheets, by placing the inter-sheet fibers on the cell sheet that is the lower layer when laminating the cell sheets, by laminating the cell sheet that is the upper layer on it, Can be placed between cell sheets.
細胞シート間にシート間繊維が配置される場合、配置されるシート間繊維の数は例えば、細胞シート1枚あたりに1本以上配置することが好ましい。また、細胞シートの面積1cm2あたりに1から10本とすることできる。 When inter-sheet fibers are arranged between cell sheets, it is preferable to arrange one or more inter-sheet fibers per cell sheet, for example. Moreover, it can be 1 to 10 per 1 cm 2 of the cell sheet area.
細胞シート積層体を構成する細胞シート数は、例えば2枚以上100枚以下であり、2以上50枚以下が好ましい。
細胞シート積層体の積層方向の厚みは、例えば20μm以上であり、好ましくは500μm以上であり、例えば10mm以下であり、好ましくは8mm以下である。
The number of cell sheets constituting the cell sheet laminate is, for example, 2 or more and 100 or less, and preferably 2 or more and 50 or less.
The thickness in the stacking direction of the cell sheet laminate is, for example, 20 μm or more, preferably 500 μm or more, for example, 10 mm or less, preferably 8 mm or less.
細胞シート積層体の積層方向に直交する面の面積は、例えば0.15cm2以上であり、好ましくは7cm2以上であり、また80cm2以下であり、好ましくは10cm2以下である。 The area of the surface perpendicular to the stacking direction of the cell sheet laminate is, for example, 0.15 cm 2 or more, preferably 7 cm 2 or more, and 80 cm 2 or less, preferably 10 cm 2 or less.
細胞シート積層体を構成する細胞シートは、複数の細胞が接着して形成される1層からなるシート状の細胞集合体である。細胞シートを構成する細胞は特に制限されず、目的等に応じて適宜選択することができる。細胞シートを構成する細胞は、ヒトを含む哺乳動物の細胞であり、例えば体細胞、その前駆細胞、及びそれらの混合細胞を挙げることができる。具体的に細胞としては、内皮細胞、間葉系幹細胞、脂肪由来幹細胞、臍帯血由来幹細胞、歯髄幹細胞、心筋細胞、心臓壁細胞、肝細胞、線維芽細胞、骨芽細胞、血管内皮細胞、肝前駆細胞、間葉系細胞、膵島細胞、軟骨細胞、上皮細胞等が挙げられ、これらからなる群から選択される少なくとも1種の細胞が好ましい。 The cell sheet constituting the cell sheet laminate is a sheet-like cell aggregate composed of one layer formed by adhering a plurality of cells. The cells constituting the cell sheet are not particularly limited and can be appropriately selected depending on the purpose and the like. The cells constituting the cell sheet are mammalian cells including humans, and examples include somatic cells, precursor cells thereof, and mixed cells thereof. Specific cells include endothelial cells, mesenchymal stem cells, adipose-derived stem cells, cord blood-derived stem cells, dental pulp stem cells, cardiomyocytes, heart wall cells, hepatocytes, fibroblasts, osteoblasts, vascular endothelial cells, liver Examples include progenitor cells, mesenchymal cells, islet cells, chondrocytes, epithelial cells, and the like, and at least one cell selected from the group consisting of these is preferred.
細胞シートを構成する細胞は、任意の方法で単離した組織に含有される細胞であってもよく、または組織から樹立された細胞株であってもよい。この他にも、多能性幹細胞から任意の方法で誘導された細胞であってもよい。この時用いる誘導方法は、当業者に周知の方法を用いることができ、特に限定されない。 The cells constituting the cell sheet may be cells contained in a tissue isolated by an arbitrary method, or may be a cell line established from the tissue. In addition, cells derived from pluripotent stem cells by any method may be used. The guidance method used at this time can be a method well known to those skilled in the art, and is not particularly limited.
細胞シートは、所望の細胞を培養器材中でシート状に培養し、シート状態で取り出すことで作製することができる。培養した細胞をシート状態で取り出す方法としては例えば、温度応答性ポリマーで被覆した培養器材を用いて細胞を培養して細胞シートを形成した後、温度を変化させることにより、培養器材から細胞シートを剥離させる方法を挙げることができる。
温度応答性ポリマーとしては、(メタ)アクリルアミド化合物、N-(若しくはN,N-ジ)アルキル置換(メタ)アクリルアミド誘導体(例えば、特開2010-255001号公報参照)、又はビニルエーテル誘導体の重合体を挙げることができる。好ましい培養器材としては、ポリ-N-イソプロピルアクリルアミドを固定した培養器材が例示される。このような培養器材は、UpCellとしてセルシード社より購入することもできる。なお、この他に温度応答性のコーティング剤でコーティングされた培養器材として、Chen CH, et al, Biomacromolecules. 7:736-43, 2006に記載のメチルセルロースをコーティングした培養器材、Takamoto Y, et al, J. Biomater. Sci. Polymer Edn, 18:1211-1222, 2007に記載の2-エトキシエチルビニルエーテルと2-フェノキシエチルビニルエーテルとのブロック共重合体をコーティングしたポリエチレンテレフタレート(PET)フィルムを有する培養器材が例示される。
The cell sheet can be produced by culturing desired cells in a sheet form in a culture device and taking out the cells in a sheet state. As a method for taking out the cultured cells in a sheet state, for example, after culturing the cells using a culture device coated with a temperature-responsive polymer to form a cell sheet, the cell sheet is removed from the culture device by changing the temperature. The method of peeling can be mentioned.
Examples of the temperature-responsive polymer include (meth) acrylamide compounds, N- (or N, N-di) alkyl-substituted (meth) acrylamide derivatives (see, for example, JP 2010-255001 A), or vinyl ether derivative polymers. Can be mentioned. As a preferable culture device, a culture device fixed with poly-N-isopropylacrylamide is exemplified. Such culture equipment can also be purchased from Cellseed as UpCell. In addition, as a culture device coated with a temperature-responsive coating agent, a culture device coated with methyl cellulose described in Chen CH, et al, Biomacromolecules. 7: 736-43, 2006, Takamoto Y, et al, A culture apparatus having a polyethylene terephthalate (PET) film coated with a block copolymer of 2-ethoxyethyl vinyl ether and 2-phenoxyethyl vinyl ether described in J. Biomater. Sci. Polymer Edn, 18: 1211-1222, 2007 Illustrated.
細胞シート積層体の培養
基材の細胞載置部上に載置された細胞シート積層体は、液体培地中で培養される。細胞シート積層体を基材上に載置し、液体培地の表面に接近させた状態で培養することで、細胞シート積層体の内部にまで充分に酸素等が供給され、細胞培養が良好な状態で行われる。これにより例えば、細胞シート間で細胞接着等が進行して一体として生理的機能を発揮し得る培養細胞構造体が形成される。
Culture of cell sheet laminate The cell sheet laminate placed on the cell placement part of the substrate is cultured in a liquid medium. By placing the cell sheet laminate on the substrate and culturing the cell sheet laminate close to the surface of the liquid medium, oxygen and the like are sufficiently supplied to the inside of the cell sheet laminate, and the cell culture is in good condition Done in Thereby, for example, cell adhesion and the like proceed between the cell sheets to form a cultured cell structure that can integrally exert a physiological function.
細胞シート積層体の培養条件は、細胞シート積層体を構成する細胞種、細胞数等に応じて所望の培養条件を選択すればよい。培養温度は、例えば約30から40℃、好ましくは約37℃である。培養は、例えばCO2含有空気の雰囲気下で行われ、CO2濃度は、例えば2から5%である。培養時間は、例えば1日から10日間である。 What is necessary is just to select desired culture conditions for the culture conditions of a cell sheet laminated body according to the cell type, cell number, etc. which comprise a cell sheet laminated body. The culture temperature is, for example, about 30 to 40 ° C, preferably about 37 ° C. The culture is performed, for example, in an atmosphere of CO 2 -containing air, and the CO 2 concentration is, for example, 2 to 5%. The culture time is, for example, 1 day to 10 days.
基材の凹部に空気を保持した状態で培養を行ってもよい。基材の細胞載置部が気体に対する透過性を有する場合、凹部に空気を保持しながら培養を行うことで、細胞シート積層体を培養液中で接着培養しながら、細胞シート積層体の底面も気液界面に近い状態で培養する事が可能となるという効果が得られる。凹部に保持される空気は、培養開始時から培養終了時までの間に少なくとも一部が交換されてもよい。凹部に保持される空気を交換する場合、その交換量は目的等に応じて適宜選択することができる。 Culturing may be performed in a state where air is retained in the recess of the substrate. When the cell placement part of the base material is permeable to gas, by culturing while holding the air in the recess, the bottom surface of the cell sheet laminate is also adhered and cultured in the culture solution. The effect that it becomes possible to culture in a state close to the gas-liquid interface is obtained. At least a part of the air held in the recess may be exchanged between the start of culture and the end of culture. When exchanging the air held in the recess, the exchange amount can be appropriately selected according to the purpose or the like.
また凹部に保持される空気の交換方法としては、例えば凹部内に一方の開口部を有する中空状の気体交換部材を介して空気を供給・回収する方法を挙げることができる。凹部に供給される空気は、気体透過性を有する細胞載置部から液体培地中に放出されてもよく、空気交換部材を介して少なくとも一部が凹部から回収されてもよい。 Further, as a method for exchanging air held in the recess, for example, a method of supplying / recovering air through a hollow gas exchange member having one opening in the recess can be cited. The air supplied to the recess may be released into the liquid medium from the cell mounting portion having gas permeability, and at least a part of the air may be recovered from the recess via the air exchange member.
凹部に保持される空気には、培養細胞に刺激を与える成分が含まれていてもよい。培養細胞に刺激を与える成分としては、例えば、一酸化窒素、窒素、一酸化炭素、二酸化炭素、水素硫化水素、酸素等を挙げることができる。凹部に保持される空気に培養細胞に刺激を与える成分が含まれる場合、その濃度は当該成分の性質、目的等に応じて適宜選択することができる。 The air retained in the recess may contain a component that gives a stimulus to the cultured cells. Examples of components that stimulate cultured cells include nitric oxide, nitrogen, carbon monoxide, carbon dioxide, hydrogen hydrogen sulfide, oxygen, and the like. When a component that stimulates cultured cells is included in the air held in the recess, the concentration can be appropriately selected according to the nature, purpose, and the like of the component.
基材の凹部に液体培地を保持した状態で培養を行ってもよい。凹部に保持される液体培地は、容器に収容される液体培地と同一でもよく、異なっていてもよい。基材の細胞載置部が液体に対する透過性を有する場合、凹部に液体培地を保持しながら培養を行うことで、細胞シート積層体を液体培地中で接着培養しながら、細胞シートの底面からも液体培地を介した栄養・酸素の供給が可能となるという効果が得られる。凹部に保持される液体培地は、培養開始時から培養終了時までの間に少なくとも一部が交換されてもよい。凹部に保持される液体培地を交換する場合、その交換量は目的等に応じて適宜選択することができる。 Culturing may be performed in a state where the liquid medium is held in the recess of the base material. The liquid medium held in the recess may be the same as or different from the liquid medium stored in the container. When the cell placement part of the base material is permeable to liquid, by culturing while holding the liquid medium in the recess, the cell sheet laminate can also be cultured from the bottom of the cell sheet while adhering culture in the liquid medium. The effect that the supply of nutrients and oxygen through a liquid medium becomes possible is obtained. At least a part of the liquid medium held in the recess may be exchanged between the start of culture and the end of culture. When exchanging the liquid culture medium held in the recess, the exchange amount can be appropriately selected according to the purpose or the like.
また凹部に保持される液体培地の交換方法としては、例えば凹部内に一方の開口部を有する中空状の液体交換部材を介して液体培地を供給・回収する方法、多孔質の液体交換部材を介して液体培地を交換する方法等を挙げることができる。中空状の液体交換部材を介して凹部に供給される液体培地は、液体透過性を有する細胞載置部から液体培地中に放出されてもよく、液体交換部材を介して少なくとも一部が凹部から回収されてもよい。また多孔質の液体交換部材を用いる場合、拡散によって液体培地が交換されてもよい。 In addition, as a method of exchanging the liquid medium held in the recess, for example, a method of supplying and recovering the liquid medium via a hollow liquid exchange member having one opening in the recess, or via a porous liquid exchange member And a method of exchanging the liquid medium. The liquid medium supplied to the recess through the hollow liquid exchange member may be discharged into the liquid medium from the cell mounting portion having liquid permeability, and at least a part of the liquid medium from the recess through the liquid exchange member. It may be recovered. When a porous liquid exchange member is used, the liquid medium may be exchanged by diffusion.
凹部に保持される液体培地には、培養細胞に刺激を与える成分が含まれていてもよい。培養細胞に刺激を与える成分としては、例えば、VEGF(Vascular endothelial growth factor)、bFGF(basic fibroblast growth factor)などの成長因子、一酸化窒素、窒素、一酸化炭素、二酸化炭素、水素、硫化水素、酸素等を挙げることができる。凹部に保持される液体培地に培養細胞に刺激を与える成分が含まれる場合、その濃度は当該成分の性質、目的等に応じて適宜選択することができる。 The liquid medium held in the recess may contain a component that stimulates the cultured cells. Examples of components that stimulate cultured cells include growth factors such as VEGF (Vascular endothelial growth factor) and bFGF (basic fibroblast growth factor), nitrogen monoxide, nitrogen, carbon monoxide, carbon dioxide, hydrogen, hydrogen sulfide, Examples thereof include oxygen. When the liquid medium held in the recess contains a component that stimulates cultured cells, the concentration can be appropriately selected according to the nature, purpose, etc. of the component.
細胞シート積層体が載置される基材は、一端が細胞載置部に貫入し、細胞シート積層体の積層方向に延在する少なくとも1本の繊維(フィラメント)を備えている。繊維は細胞載置部裏面に設けられた凹部に向けて細胞載置部を貫通している。また、細胞シート積層体の積層方向に延在する繊維は、細胞シート積層体と接触していてもよく、細胞シート積層体を貫通していてもよい。
繊維の少なくとも1本は前記細胞シート積層体を貫通していることが好ましい。特に、複数本の繊維が配置され、その本数の大部分が細胞シート積層体を貫通していることが好ましい。細胞シート積層体の面積が小さい場合は、貫通する繊維の本数に比較して貫通していない繊維の本数が多くなってもよく、細胞シート積層体を貫通せずに接触する繊維のみからなっていてもよい。
基材が繊維を備えることで、例えば繊維が気体・液体の透過性を有する場合、繊維を介して細胞シート積層体内部に培地や空気を供給可能となるという効果や細胞シート積層体を載置部に安定的に固定するという効果が得られる。
The base material on which the cell sheet laminate is placed includes at least one fiber (filament) having one end penetrating into the cell placement portion and extending in the stacking direction of the cell sheet laminate. The fiber penetrates the cell placement portion toward the recess provided on the back surface of the cell placement portion. Moreover, the fiber extended in the lamination direction of a cell sheet laminated body may be in contact with the cell sheet laminated body, and may penetrate the cell sheet laminated body.
It is preferable that at least one of the fibers penetrates the cell sheet laminate. In particular, it is preferable that a plurality of fibers are arranged and most of the number of the fibers penetrates the cell sheet laminate. When the area of the cell sheet laminate is small, the number of non-penetrating fibers may be larger than the number of fibers that penetrate, and it consists only of fibers that do not penetrate the cell sheet laminate. May be.
By providing the substrate with fibers, for example, when the fibers have gas / liquid permeability, it is possible to supply a medium or air into the cell sheet laminate through the fibers, or the cell sheet laminate is placed. The effect that it is stably fixed to the part is obtained.
繊維の材質としては例えば、エチレン-テトラフルオロエチレン共重合体(ETFE)、テトラフルオロエチレン-パーフルオロアルキルビニルエーテル共重合体(FEP)、CYTOP(商品名、旭硝子社製)、フレミオン(商品名、旭硝子社製)、テフロンAF1600(商品名、三井・デュポン フロロケミカル社製)、テフロンAF2400(商品名、三井・デュポン フロロケミカル社製)、ポリジメチルシロキサン(PDMS)、架橋したゼラチンハイドロゲル等を挙げることができ、酸素透過性材料を含むことが好ましい。更に培地を供給可能な材質であることもまた好ましい。また繊維は培地で膨潤することが好ましい。膨潤すると培地と共に酸素の供給が良好となる。 Examples of the fiber material include ethylene-tetrafluoroethylene copolymer (ETFE), tetrafluoroethylene-perfluoroalkyl vinyl ether copolymer (FEP), CYTOP (trade name, manufactured by Asahi Glass Co., Ltd.), and Flemion (trade name, Asahi Glass). Teflon AF1600 (trade name, manufactured by Mitsui DuPont Fluorochemical Co., Ltd.), Teflon AF2400 (trade name, manufactured by Mitsui DuPont Fluorochemical Co., Ltd.), polydimethylsiloxane (PDMS), cross-linked gelatin hydrogel, etc. It is preferable to include an oxygen permeable material. Furthermore, it is also preferable that the material is capable of supplying a medium. Moreover, it is preferable that a fiber swells with a culture medium. When it swells, the supply of oxygen is improved along with the medium.
繊維の構造は、多孔質体、中空体、中実体等のいずれであってもよい。凹部と液体又は気体を交換する点から、多孔質体又は中空体であることが好ましい。繊維が多孔質体又は中空体であると、液体又は気体を容易に交換することができる。すなわち、基材が備える繊維は、上記気体交換部材又は液体交換部材を兼ねるものであってもよい。 The fiber structure may be any of a porous body, a hollow body, a solid body, and the like. From the viewpoint of exchanging liquid or gas with the concave portion, a porous body or a hollow body is preferable. When the fiber is a porous body or a hollow body, the liquid or gas can be easily exchanged. That is, the fiber provided in the base material may serve as the gas exchange member or the liquid exchange member.
繊維の太さは、例えば直径として0.1μm以上5000μm以下、好ましくは1μm以上1000μm以下、より好ましくは10μm以上500μm以下である。繊維が中空体の場合、中空部分の直径は例えば0.1μm以上5000μm以下であり、好ましくは10μm以上500μm以下である。
繊維の長さは、細胞シート積層体の厚みより長ければ特に限定されず、例えば2mm以上50mm以下であり、好ましくは5mm以上30mm以下である。
The thickness of the fiber is, for example, 0.1 μm or more and 5000 μm or less as a diameter, preferably 1 μm or more and 1000 μm or less, and more preferably 10 μm or more and 500 μm or less. When the fiber is a hollow body, the diameter of the hollow portion is, for example, not less than 0.1 μm and not more than 5000 μm, preferably not less than 10 μm and not more than 500 μm.
The length of a fiber will not be specifically limited if it is longer than the thickness of a cell sheet laminated body, For example, they are 2 mm or more and 50 mm or less, Preferably they are 5 mm or more and 30 mm or less.
基材が備える繊維の数は、細胞シート積層体の厚み、大きさ等に応じて適宜選択すればよい。繊維の数は、例えば細胞シートの面積1cm2あたり、0.01から1000本であり、好ましくは0.1から100本、より好ましくは0.1から50本である。
基材が備える繊維の全数に対する細胞シート積層体を貫通する繊維の本数の割合は、50%から100%が好ましく、80%から100%がより好ましい。
What is necessary is just to select suitably the number of the fibers with which a base material is provided according to the thickness of a cell sheet laminated body, a magnitude | size, etc. The number of fibers is, for example, from 0.01 to 1000, preferably from 0.1 to 100, and more preferably from 0.1 to 50, per 1 cm 2 of the cell sheet area.
The ratio of the number of fibers penetrating the cell sheet laminate to the total number of fibers provided in the substrate is preferably 50% to 100%, more preferably 80% to 100%.
繊維を備える基材上で細胞シート積層体を培養する方法について、図面を参照して説明する。図1は、本実施形態に係る細胞シート積層体の培養方法の一例を模式的に示す概略断面図である。図1では、容器2に液体培地16が収容され、基材4が容器2の内部に配置されている。基材4の細胞載置部6の表面上には、搬送用基材12を介して細胞シート積層体14が載置されている。別の態様においては、搬送用基材12を介することなく、細胞載置部6の表面上に細胞シート積層体14が直接載置されていてもよい。細胞載置部6の裏面には凹部8が形成されており、凹部8には液体培地16が保持されている。凹部8には液体培地16に代えて空気が保持されていてもよい。細胞載置部6の表面上に載置された細胞シート積層体は、容器内壁の底面18に載置されるよりも液体培地の表面に近い位置で培養される。
A method for culturing a cell sheet laminate on a substrate having fibers will be described with reference to the drawings. FIG. 1 is a schematic cross-sectional view schematically showing an example of a method for culturing a cell sheet laminate according to the present embodiment. In FIG. 1, the
また基材4は、凹部8に向けて細胞載置部6を貫通する繊維10を備え、繊維10は、細胞シート積層体14を貫通し、細胞シート積層体14の積層方向に延在している。図1では、繊維10は細胞シート積層体14を積層方向に貫通しているが、細胞シート積層体14を貫通せずに、細胞シート積層体14の側面に接していてもよい。図1では、繊維10の端部の一方は凹部8に位置し、他方の端部は液体培地中に位置しているが、他方の端部は液体培地16の外に位置していてもよい。
Moreover, the
本実施形態の製造方法で製造される培養細胞構造体は、従来の培養方法では内部が壊死するような厚みを持ちながら高い細胞活性を維持するという特徴を有し、創薬研究や再生医療等の用途に適用することができる。 The cultured cell structure produced by the production method of the present embodiment has a feature of maintaining high cell activity while having a thickness that causes necrosis inside the conventional culture method, such as drug discovery research and regenerative medicine. It can be applied to any use.
以下、本発明を実施例により具体的に説明するが、本発明はこれらの実施例に限定されるものではない。なお、培養細胞構造体の評価は、以下に示すようにして免疫染色及びウェスタンブロット解析により行った。 Hereinafter, the present invention will be specifically described by way of examples. However, the present invention is not limited to these examples. The cultured cell structure was evaluated by immunostaining and Western blot analysis as described below.
免疫染色
得られた培養細胞構造体をリン酸緩衝生理食塩水(PBS)で2回洗浄後、4%パラホルムアルデヒドで固定し、OCTコンパウンドで固めてクライオスタットで10μm厚に薄切して、凍結切片を作製した。なお、凍結切片は積層方向に平行な断面が観察できるように作製した。
免疫染色は、低酸素マーカーであるHypoxyprobe(コスモバイオ社製)、細胞呼吸マーカーであるピルビン酸デヒドロゲナーゼ(Pyruvate dehydrogenase;PDH)抗体(SANTA CRUZ BIOTECHNOLOGY)、細胞増殖マーカーであるKi-67抗体(SANTA CRUZ BIOTECHNOLOGY)を用いて行った。免疫染色した培養細胞構造体の画像を図5から10に示す。
Immunostaining The obtained cultured cell structure was washed twice with phosphate buffered saline (PBS), fixed with 4% paraformaldehyde, solidified with OCT compound, sliced into 10 μm thickness with a cryostat, and frozen section. Was made. The frozen section was prepared so that a cross section parallel to the stacking direction could be observed.
Immunostaining includes hypoxia probe (Hypoxyprobe), a hypoxia marker, pyruvate dehydrogenase (PDH) antibody (SANTA CRUZ BIOTECHNOLOGY), a cell respiration marker, Ki-67 antibody (Santa TA), a cell proliferation marker. BIOTECHNOLOGY). Images of immunostained cultured cell structures are shown in FIGS.
ウェスタンブロット解析
得られた培養細胞構造体をLysis bufferに入れてホモジナイズし、上清を回収した。ドデシル硫酸ナトリウム(SDS)サンプルバッファーで希釈後、50μg/wellとなるようにアクリルアミドゲルにアプライし、電気泳動によってタンパク質を展開した。展開したタンパク質をPVdF(Polyvinylidene difluoride)膜に転写し、ピルビン酸デヒドロゲナーゼ及びKi-67の一次抗体でそれぞれ処理した。所定時間処理後、TBST(Tris Buffered Saline with Tween20)、でPVdF膜を洗浄し、HRP(西洋ワサビペルオキシダーゼ)コンジュゲート二次抗体で処理した。所定時間処理後、再びTBSTで洗浄しSuperSignal Chemiluminescent Substrate(Thermo scientific)で処理し、LAS4000(商品名、富士フイルム社製)を用いて可視化した。得られた画像は画像解析ソフトImage Jを用いて相対定量した。
評価結果を図2~4及び11に示す。
Western blot analysis The obtained cultured cell structure was placed in a Lysis buffer and homogenized, and the supernatant was collected. After diluting with sodium dodecyl sulfate (SDS) sample buffer, it was applied to an acrylamide gel to 50 μg / well, and the protein was developed by electrophoresis. The developed protein was transferred to a PVdF (Polyvinylidene difluoride) membrane and treated with primary antibodies of pyruvate dehydrogenase and Ki-67, respectively. After treatment for a predetermined time, the PVdF membrane was washed with TBST (Tris Buffered Saline with Tween 20), and then treated with an HRP (horseradish peroxidase) -conjugated secondary antibody. After the treatment for a predetermined time, it was washed again with TBST, treated with SuperSignal Chemiluminescent Substrate (Thermo scientific), and visualized using LAS4000 (trade name, manufactured by Fuji Film). The obtained image was subjected to relative quantification using image analysis software Image J.
The evaluation results are shown in FIGS.
(参考例)
中空糸の作製
内径400μmのシリンジ針(テルモ社製)の外表面にディップコーターを用いて樹脂をコーティングした。溶液濃度、引き上げ速度を調整することで乾燥状態での樹脂膜厚が20~30μmになるようにコーティング膜を作製した。なお、針からの剥離性向上のためシリンジ針に犠牲層をプレコートしてもよい。
細胞シートの作製
液体培地として、MEMαに10%ウシ胎児血清(FBS)、1%ペニシリン/ストレプトマイシンを添加したものを用意した。細胞培養用ポリスチレン6wellプレートに、培地量2mLでヒト間葉系幹細胞株(hMSC)を20万cells/wellとなるように播種し、3日ごとに培地交換しながら8~10日間培養して、プレート上に細胞シートを形成した。
(Reference example)
Production of Hollow Fiber A resin was coated on the outer surface of a syringe needle (Terumo) having an inner diameter of 400 μm using a dip coater. A coating film was prepared by adjusting the solution concentration and the pulling speed so that the resin film thickness in a dry state was 20 to 30 μm. Note that a sacrificial layer may be precoated on the syringe needle in order to improve the peelability from the needle.
Preparation of Cell Sheet A liquid medium prepared by adding 10% fetal bovine serum (FBS) and 1% penicillin / streptomycin to MEMα was prepared. A cell culture polystyrene 6-well plate is seeded with 2 mL of a medium in a human mesenchymal stem cell line (hMSC) to 200,000 cells / well, and cultured for 8 to 10 days while changing the medium every 3 days. A cell sheet was formed on the plate.
細胞シート積層体の作製
10cm細胞培養用PSシャーレを0.1%ゼラチン水溶液で室温、10分間処理した。上記で形成された細胞シートをピペッティングにより剥がし、剥がれた細胞シートをデカンテーション又は口径の大きいピペットチップで吸い込んでゼラチンコートしたPSシャーレに移した。ピペットで培地を滴下して細胞シートの皺を伸ばした。滴下した培地を吸い取り、37℃、5%CO2のインキュベーター中で30分間静置して、細胞シートをシャーレに接着させた。
同様にして次の細胞シートを培地とともにシャーレに移し、接着させた細胞シート上に重ね、ピペットで培地を滴下して細胞シートの皺を伸ばした後、培地を吸い取り、37℃、5%CO2のインキュベーター中で30分間静置して、細胞シートを積層した。
細胞シートの積層操作を所定の回数繰り返して、所定枚数の細胞シートが積層された細胞シート積層体を得た。積層体を細胞載置部に移して培養する場合は、搬送用基材としてVECELL膜を用い、PSシャーレからヘラ等で剥がした積層体をVECELL膜に吸着させて載置部に移した。PSシャーレで培養する場合は、積層体にそのまま培地を注いで培養した。また、6枚以上の細胞シートを積層する際は、3枚~10枚のシートを積層した積層体を、VECELL膜を用いて別の積層体上に搬送し、VECELL膜を剥がすことによって積層体同士を順次積層することで作製することもできる。
Preparation of cell
In the same manner, the next cell sheet is transferred to a petri dish together with the culture medium, stacked on the adhered cell sheet, and after dropping the culture medium with a pipette to stretch the cell sheet wrinkles, the culture medium is sucked off, and the medium is sucked at 37 ° C, 5% CO 2. In the incubator for 30 minutes to laminate the cell sheets.
The cell sheet lamination operation was repeated a predetermined number of times to obtain a cell sheet laminate in which a predetermined number of cell sheets were laminated. When the laminate was transferred to the cell placement section and cultured, a VECELL film was used as a transport substrate, and the laminate peeled off from the PS petri dish with a spatula or the like was adsorbed to the VECELL film and transferred to the placement section. When culturing in a PS petri dish, the medium was poured directly into the laminate and cultured. In addition, when stacking 6 or more cell sheets, the stacked body in which 3 to 10 sheets are stacked is transported onto another stacked body using a VECELL film, and the stacked body is peeled off. It can also be produced by sequentially laminating each other.
(比較例1)
10cm細胞培養用PSシャーレの内壁底面に5枚の細胞シートからなる細胞シート積層体を載置し、MEM-α培地(10% ウシ胎児血清, 1% ペニシリン/ストレプトマイシン)10mLをいれた。37℃、5%CO2のインキュベーター中で、所定期間培養を行った。
培養後に得られた培養細胞構造体について、凍結切片法による免疫染色とウェスタンブロット解析により評価した。
低酸素マーカー、細胞増殖マーカー及び細胞呼吸マーカーを免疫染色した画像をそれぞれ図6、図8及び図10に示す。また、ウェスタンブロット解析の結果を図2、3に示す。
(Comparative Example 1)
A cell sheet laminate comprising 5 cell sheets was placed on the bottom of the inner wall of a 10 cm cell culture PS petri dish, and 10 mL of MEM-α medium (10% fetal bovine serum, 1% penicillin / streptomycin) was added. Culturing was performed for a predetermined period in an incubator at 37 ° C. and 5% CO 2 .
The cultured cell structure obtained after the culture was evaluated by immunostaining by the frozen section method and Western blot analysis.
Images obtained by immunostaining the hypoxia marker, cell proliferation marker and cell respiration marker are shown in FIGS. 6, 8 and 10, respectively. The results of Western blot analysis are shown in FIGS.
(比較例2)
LUMOX35mmディッシュの円周部を削って高さを調整した。10cm細胞培養用PSシャーレ内にディッシュを反転させて、ディッシュの底面が細胞載置部となるように接着し、滅菌処理して培養基材とした。ディッシュの底面にVECELL膜上に形成された10枚の細胞シートからなる細胞シート積層体を載置し、細胞シート積層体の最表面が被る程度にまで培地をいれた。この時、シャーレ内の培地の高さに対するディッシュの底面の高さの比は、0.9であった。37℃、5%CO2のインキュベーター中で、所定期間培養を行い、ウェスタンブロット解析により評価した。ウェスタンブロット解析の結果は、図11に示す。
(Comparative Example 2)
The circumference of the LUMOX 35 mm dish was cut to adjust the height. The dish was inverted in a 10 cm cell culture PS petri dish, adhered so that the bottom surface of the dish became a cell placement portion, and sterilized to obtain a culture substrate. A cell sheet laminate comprising 10 cell sheets formed on the VECELL film was placed on the bottom of the dish, and the medium was added to such an extent that the outermost surface of the cell sheet laminate was covered. At this time, the ratio of the height of the bottom surface of the dish to the height of the medium in the petri dish was 0.9. The cells were cultured for a predetermined period in an incubator at 37 ° C. and 5% CO 2 and evaluated by Western blot analysis. The results of Western blot analysis are shown in FIG.
(実施例1)
内径400μmのシリンジ針の外表面にCYTOP CTL-109S(商品名、旭硝子社製)をコートして、壁厚約30μmの中空フィラメントを作製した。作製した中空フィラメントのSEM画像を図12に示す。図12の左図は拡大率100倍の画像、右図は拡大率1000倍の画像である。
ディッシュの底面にVECELL膜上に形成された5枚の細胞シートからなる細胞シート積層体を載置した後、中空フィラメントをシリンジ針と共に、細胞シート積層体、VECELL膜及びディッシュ底面を貫通させ、フィラメントをピンセットで押えながらシリンジ針を引き抜いた。残ったフィラメントは、一方の端がディッシュ内にあり、他方の端が培地表面から空気中に露出した状態となった。フィラメントを、0.8cm2あたり2本の割合で細胞シート積層体を貫通した状態に配置したことと、細胞シートの積層枚数を5枚にしたこと以外は、比較例2と同様にして細胞シート積層体を培養し、凍結切片法による免疫染色とウェスタンブロット解析により評価した。評価結果を図2及び3に示す。また低酸素マーカー、細胞増殖マーカー及び細胞呼吸マーカーを免疫染色した画像をそれぞれ図5、図7及び図9に示す。
Example 1
CYTOP CTL-109S (trade name, manufactured by Asahi Glass Co., Ltd.) was coated on the outer surface of a syringe needle having an inner diameter of 400 μm to produce a hollow filament having a wall thickness of about 30 μm. The SEM image of the produced hollow filament is shown in FIG. The left figure of FIG. 12 is an image with a magnification of 100 times, and the right figure is an image with a magnification of 1000 times.
After placing the cell sheet laminate consisting of five cell sheets formed on the VECELL film on the bottom of the dish, the hollow filament is penetrated through the cell sheet laminate, the VECELL membrane and the dish bottom together with the syringe needle, and the filament The syringe needle was pulled out while pressing with tweezers. The remaining filament was in a state where one end was in the dish and the other end was exposed to the air from the medium surface. The cell sheet was the same as Comparative Example 2 except that the filaments were arranged in a state of penetrating the cell sheet laminate at a rate of 2 per 0.8 cm 2 and that the number of laminated cell sheets was 5. Laminates were cultured and evaluated by immunostaining by Western section and Western blot analysis. The evaluation results are shown in FIGS. Moreover, the image which immunostained the hypoxia marker, the cell proliferation marker, and the cell respiration marker is shown in FIG.5, FIG.7 and FIG.9, respectively.
免疫染色の結果から、比較例1(図6、図8及び図10)に比べて実施例1の方が、低酸素マーカー分子(Hypoxyprobe)の染色が弱く、細胞呼吸マーカータンパク質(PDH)及び細胞増殖マーカータンパク質(Ki-67)の染色が強く観察された。
また、ウェスタンブロット解析の結果(図2及び3)から、比較例1に比べて実施例1の方が、細胞呼吸マーカータンパク質(PDH)及び細胞増殖マーカータンパク質(Ki-67)の発現量が多かったことが分かる。
From the result of immunostaining, the staining of hypoxic marker molecule (Hyoxyprobe) was weaker in Example 1 than in Comparative Example 1 (FIGS. 6, 8 and 10), and the cell respiration marker protein (PDH) and the cells Staining of proliferation marker protein (Ki-67) was strongly observed.
Also, from the results of Western blot analysis (FIGS. 2 and 3), the expression level of cell respiration marker protein (PDH) and cell proliferation marker protein (Ki-67) was higher in Example 1 than in Comparative Example 1. I understand that.
(実施例2)
CYTOP CTL-109Sの代わりにテフロンAF1600(商品名、三井・デュポン フロロケミカル社製)を用いたこと以外は実施例1と同様にして細胞シート積層体を培養し、同様に評価したところ、実施例1と同様の結果が得られた。
(Example 2)
The cell sheet laminate was cultured and evaluated in the same manner as in Example 1 except that Teflon AF1600 (trade name, manufactured by Mitsui DuPont Fluorochemical Co., Ltd.) was used instead of CYTOP CTL-109S. Results similar to 1 were obtained.
(実施例3)
内径400μmのシリンジ針の外表面にCYTOP CTL-109Sをコートして、中空フィラメントを作製した。ディッシュの底面にVECELL膜上に形成された細胞シート積層体を載置した後、中空フィラメントをシリンジ針と共に、細胞シート積層体、VECELL膜及びディッシュ底面を貫通させ、フィラメントをピンセットで押えながらシリンジ針を引き抜いた。残ったフィラメントは、一方の端がディッシュ内にあり、他方の端が培地表面から空気中に露出した状態となった。フィラメントを、細胞シート積層体の中心を貫通するように1本だけ配置したこと以外は、実施例1と同様にして細胞シート積層体を培養した。4日間培養後、ファイバーを貫通させた位置を中心として5mmφに細胞シート積層体を打ち抜き、実施例1と同様にして細胞呼吸マーカーであるPDHの発現量を評価した。評価結果を図4に示す。図4の縦軸はアクチン発現量で補正したPDH発現量である。
(Example 3)
CYTOP CTL-109S was coated on the outer surface of a syringe needle having an inner diameter of 400 μm to produce a hollow filament. After placing the cell sheet laminate formed on the VECELL membrane on the bottom of the dish, the hollow filament is passed through the cell sheet laminate, the VECELL membrane and the bottom of the dish together with the syringe needle, and the syringe needle while pressing the filament with tweezers Pulled out. The remaining filament was in a state where one end was in the dish and the other end was exposed to the air from the medium surface. The cell sheet laminate was cultured in the same manner as in Example 1 except that only one filament was disposed so as to penetrate the center of the cell sheet laminate. After culturing for 4 days, the cell sheet laminate was punched out to 5 mmφ centering on the position where the fiber penetrated, and the expression level of PDH as a cell respiration marker was evaluated in the same manner as in Example 1. The evaluation results are shown in FIG. The vertical axis in FIG. 4 is the PDH expression level corrected with the actin expression level.
(比較例3)
フィラメントの代わりに400μm径のシリンジ針を細胞シート積層体の中心を貫通するように1本だけ配置したこと以外は実施例3と同様にして細胞シート積層体を培養し、同様に評価した。評価結果を図4に示す。
(Comparative Example 3)
The cell sheet laminate was cultured and evaluated in the same manner as in Example 3 except that only one 400 μm diameter syringe needle was used instead of the filament so as to penetrate the center of the cell sheet laminate. The evaluation results are shown in FIG.
図4から、シリンジ針を用いた比較例3よりも、繊維を用いた実施例3の方が、PDHの発現量が多かったことが分かる。また、片側検定では有意水準5%で有意差が認められた。 FIG. 4 shows that the amount of PDH expressed was higher in Example 3 using fibers than in Comparative Example 3 using syringe needles. In the one-sided test, a significant difference was recognized at a significance level of 5%.
(実施例4)
CYTOP CTL-109Sの代わりにテフロンAF1600を用いたこと以外は実施例3と同様にして細胞シート積層体を培養し、同様に評価したところ、実施例3と同様の結果が得られた。
Example 4
When the cell sheet laminate was cultured and evaluated in the same manner as in Example 3 except that Teflon AF1600 was used instead of CYTOP CTL-109S, the same results as in Example 3 were obtained.
(実施例5)
CYTOP CTL-109Sの代わりにフレミオンEW909(商品名、旭硝子社製)を用い、シリンジ針に犠牲層としてゼラチン膜をプレコートし、フレミオンEW909をオーブンで120℃、10分間アニールしたこと、1.76cm2あたり1本の割合で細胞シート積層体を貫通した状態にフィラメントを配置したこと以外は、比較例2と同様にして細胞シート積層体を培養し、ウェスタンブロット解析により評価した。作製した中空フィラメントの壁厚は約25μmだった。作製した中空フィラメントのSEM画像を図13に示す。図13の左図は拡大率100倍の画像、右図は拡大率1000倍の画像である。
評価結果を図11に示す。
(Example 5)
Flemion EW909 (trade name, manufactured by Asahi Glass Co., Ltd.) was used instead of CYTOP CTL-109S, a gelatin film was pre-coated on the syringe needle as a sacrificial layer, and Flemion EW909 was annealed in an oven at 120 ° C. for 10 minutes, 1.76 cm 2 The cell sheet laminate was cultured and evaluated by Western blot analysis in the same manner as in Comparative Example 2 except that the filaments were arranged in a state of penetrating the cell sheet laminate at a rate of about 1. The wall thickness of the produced hollow filament was about 25 μm. FIG. 13 shows an SEM image of the produced hollow filament. The left figure of FIG. 13 is an image with a magnification of 100 times, and the right figure is an image with a magnification of 1000 times.
The evaluation results are shown in FIG.
(実施例6)
CYTOP CTL-109Sの代わりにフレミオンEW909を用い、シリンジ針の外表面に犠牲層としてゼラチン膜をプレコートし、フレミオンをオーブンで120℃、10分間アニールしたこと、1.76cm2あたり3本の割合で細胞シート積層体を貫通した状態にフィラメントを配置したこと以外は、比較例2と同様にして細胞シート積層体を培養し、ウェスタンブロット解析により評価した。評価結果を図11に示す。
図11から繊維を用いない比較例2より、繊維を用いる実施例5、6の方が有意にPDHの発現量が多かった事がわかる。また繊維の本数が1本より3本の方が、PDH発現量が高くなる傾向がみられる。
(Example 6)
Flemion EW909 was used in place of CYTOP CTL-109S, a gelatin film was precoated as a sacrificial layer on the outer surface of the syringe needle, and Flemion was annealed in an oven at 120 ° C. for 10 minutes at a rate of 3 per 1.76 cm 2. The cell sheet laminate was cultured and evaluated by Western blot analysis in the same manner as in Comparative Example 2 except that the filament was disposed in a state of penetrating the cell sheet laminate. The evaluation results are shown in FIG.
It can be seen from FIG. 11 that Comparative Example 2 using no fiber showed significantly higher PDH expression in Examples 5 and 6 using fiber. Moreover, the tendency for the PDH expression level to become higher is seen when the number of fibers is three than one.
(実施例7)
内径400μmのシリンジ針の外表面にゼラチンハイドロゲルをコートして、真空オーブン中で140℃、72時間熱架橋することで中空フィラメントを作製した。CYTOP CTL-109Sの代わりに架橋したゼラチンハイドロゲルを用いたこと以外は実施例3と同様にして細胞シート積層体を培養し、同様に評価したところ、実施例3と同様の結果が得られた。
(Example 7)
A hollow filament was prepared by coating gelatin hydrogel on the outer surface of a syringe needle having an inner diameter of 400 μm and thermally crosslinking in a vacuum oven at 140 ° C. for 72 hours. The cell sheet laminate was cultured and evaluated in the same manner as in Example 3 except that a crosslinked gelatin hydrogel was used instead of CYTOP CTL-109S, and the same results as in Example 3 were obtained. .
(実施例8)
CYTOP CTL-109Sの代わりにフレミオンEW909を用い、シリンジ針の外表面に犠牲層としてゼラチン膜をプレコートし、フレミオンEW909をオーブンで120℃、10分間アニールしたこと、および細胞シートの間に特許文献2に記載の方法で粒子径20μmから32μmのゼラチンハイドロゲル粒子を挟み45枚のシートを積層したこと以外は実施例3と同様にして細胞シート積層体を培養した。
所定期間培養を行い、細胞シート積層体が安定的に基材に保持されるかどうかを検討したところ、2日以上培養しても積層体が安定的に基材上に保持されていた。
(Example 8)
Flemion EW909 was used instead of CYTOP CTL-109S, a gelatin film was precoated as a sacrificial layer on the outer surface of the syringe needle, Flemion EW909 was annealed in an oven at 120 ° C. for 10 minutes, and between the cell sheets. A cell sheet laminate was cultured in the same manner as in Example 3 except that 45 sheets were laminated by sandwiching gelatin hydrogel particles having a particle diameter of 20 μm to 32 μm by the method described in 1.
After culturing for a predetermined period and examining whether the cell sheet laminate was stably held on the substrate, the laminate was stably held on the substrate even after culturing for 2 days or more.
(比較例4)
シャーレ内にディッシュを配置しなかったこと、細胞シート間に特許文献2に記載の方法で粒子径20μmから32μmのゼラチンハイドロゲル粒子を挟み、45枚の細胞シートを積層した細胞シート積層体をシャーレの内壁底面に載置したこと以外は、実施例1と同様にして細胞シート積層体を培養し、細胞シート積層体がシャーレ上で安定的に培養されるかを検討した。
その結果、培養2日目で細胞シート積層体がシャーレから剥離して収縮したり、シート間で剥離してバラバラになったりした。
なお、2016年10月12日に出願された日本特許出願2016-200864号の明細書、特許請求の範囲、図面および要約書の全内容をここに引用し、本発明の明細書の開示として、取り入れるものである。
(Comparative Example 4)
A cell sheet laminate in which gelatin hydrogel particles having a particle diameter of 20 μm to 32 μm were sandwiched between the cell sheets by the method described in
As a result, on the second day of culture, the cell sheet laminate peeled from the petri dish and contracted, or peeled between the sheets and fell apart.
It should be noted that the entire content of the specification, claims, drawings and abstract of Japanese Patent Application No. 2016-200864 filed on October 12, 2016 is cited herein as the disclosure of the specification of the present invention. Incorporated.
2:容器、4:基材、6:細胞載置部、8:凹部、10:繊維、12:搬送用基材、14:細胞シート積層体、16:液体培地 2: Container, 4: Substrate, 6: Cell placement unit, 8: Recess, 10: Fiber, 12: Transport substrate, 14: Cell sheet laminate, 16: Liquid medium
Claims (15)
基材の細胞載置部上の細胞シート積層体を、液体培地中で培養することと、
を含み、
前記基材は細胞載置部裏面に凹部を有し、
前記基材は、前記凹部に向けて前記細胞載置部を貫通する少なくとも1本の繊維を備え、細胞シート積層体を、当該繊維が積層方向に延在する状態で培養する、培養細胞構造体の製造方法。 Placing a cell sheet laminate in which two or more cell sheets are laminated on the surface of a cell placement part of a substrate placed in a container containing a liquid medium;
Culturing the cell sheet laminate on the cell placement part of the substrate in a liquid medium;
Including
The base material has a recess on the back surface of the cell placement portion,
The base material includes at least one fiber penetrating the cell placement portion toward the concave portion, and the cell sheet laminate is cultured in a state where the fiber extends in the stacking direction. Manufacturing method.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016-200864 | 2016-10-12 | ||
| JP2016200864A JP2019213457A (en) | 2016-10-12 | 2016-10-12 | Manufacturing method of cultured cell structure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2018070441A1 true WO2018070441A1 (en) | 2018-04-19 |
Family
ID=61905313
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2017/036866 Ceased WO2018070441A1 (en) | 2016-10-12 | 2017-10-11 | Method for producing culture cell structure |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JP2019213457A (en) |
| WO (1) | WO2018070441A1 (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008123614A1 (en) * | 2007-03-30 | 2008-10-16 | Kyushu University, National University Corporation | Method for production of three-dimensional structure of cells |
| WO2014192909A1 (en) * | 2013-05-31 | 2014-12-04 | iHeart Japan株式会社 | Layered cell sheet incorporating hydrogel |
-
2016
- 2016-10-12 JP JP2016200864A patent/JP2019213457A/en active Pending
-
2017
- 2017-10-11 WO PCT/JP2017/036866 patent/WO2018070441A1/en not_active Ceased
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008123614A1 (en) * | 2007-03-30 | 2008-10-16 | Kyushu University, National University Corporation | Method for production of three-dimensional structure of cells |
| WO2014192909A1 (en) * | 2013-05-31 | 2014-12-04 | iHeart Japan株式会社 | Layered cell sheet incorporating hydrogel |
Non-Patent Citations (1)
| Title |
|---|
| SHIMIZU: "Cell Sheet-Based Tissue Engineering for Fabricating 3-Dimentional Heart Tissues", CIRCULATION JOURNAL, vol. 78, 2014, pages 2594 - 2603, XP055476194 * |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2019213457A (en) | 2019-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Liu et al. | Porous nanofibrous poly (L-lactic acid) scaffolds supporting cardiovascular progenitor cells for cardiac tissue engineering | |
| JP6948261B2 (en) | Method for cryopreserving pluripotent stem cells or cardiomyocytes derived from adipose tissue or bone marrow-derived mesenchymal stem cells | |
| CN107208053A (en) | Use mass propgation method, device and the kit of the cell of polyimide foraminous plasma membrane | |
| CN108410797A (en) | The expanding stem cells in hollow-fiber bioreactor | |
| JP2016093149A (en) | Cell culture apparatus, and cell culture method | |
| WO2016060260A1 (en) | Tissue fragment | |
| CN105229145A (en) | The manufacture method of sheet cell culture | |
| JP6690001B2 (en) | Cell tissue manufacturing method and porous film | |
| JP7282232B2 (en) | Methods for modifying adherent cell cultures | |
| CN107208031A (en) | Cell culture methods and kits | |
| CN107075443B (en) | Three-dimensional cell culture system and cell culture method using the same | |
| JP4220756B2 (en) | Incubator, incubator production method and culture method | |
| US20140024117A1 (en) | Extracellular Matrix Films And Methods Of Making And Using Same | |
| JP2015165783A (en) | Cell mass production method comprising pluripotent stem cells | |
| US20240368508A1 (en) | Stackable plates for culturing tissue models | |
| JPWO2018155607A1 (en) | Cell processing apparatus, suspension culture device, and stem cell induction method | |
| US20240216440A1 (en) | String-like aggregates of retinal pigment epithelial cells, device and production method for producing same, and therapeutic agent comprising said string-like aggregates | |
| WO2018070441A1 (en) | Method for producing culture cell structure | |
| CN116583595A (en) | Culture Components and Their Uses | |
| JP7672796B2 (en) | Spheroids and method for producing same | |
| WO2021065984A1 (en) | Method for forming sheet of cardiomyocytes | |
| JP2016013111A (en) | A culture vessel that can be peeled off from the bottom | |
| JP2023105226A (en) | Method for producing hepatocyte culture, porous film containing cells, and method for improving or maintaining function of hepatocyte or hepatic progenitor cell | |
| JP2017077240A (en) | Adhesive cell culturing substrate, and cell culture vessel and cell culture method using the same | |
| US20220002677A1 (en) | Transfer method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 17860390 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 17860390 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: JP |